Downloads: 1
Diff of
/clusters/3009knumclusters/clust_184.txt
[000000]
..
[c09aa8]
Switch to unified view
| a | b/clusters/3009knumclusters/clust_184.txt | ||
|---|---|---|---|
| 1 | Serum creatinine =< 2 x ULN |
||
| 2 | Serum creatinine =< 1.5 x ULN |
||
| 3 | Creatinine =< 1.5 times ULN |
||
| 4 | Serum creatinine =< 2 x ULN |
||
| 5 | Creatinine < 1.5 x ULN |
||
| 6 | Serum or plasma creatinine =< 1.5 x ULN measured within 28 days prior to randomization |
||
| 7 | Serum creatinine < 1.5 x ULN; the values must be obtained within 48 hours prior to randomization |
||
| 8 | Creatinine =< 1.5 x ULN obtained =< 21 days prior to registration |
||
| 9 | Creatinine =< 1.5 |
||
| 10 | Creatinine ? 2.0x ULN |
||
| 11 | creatinine <1.5 × institutional ULN OR |
||
| 12 | Serum creatinine =< 2.5 times ULN |
||
| 13 | Creatinine =< 1.5 x ULN |
||
| 14 | Creatinine less than 1.5 times the ULN |
||
| 15 | Renal insufficiency with serum creatinine > 1.6 |
||
| 16 | Creatinine (Creat) =< 1.5 X ULN |
||
| 17 | Serum creatinine =< 1.5 x ULN (for treatment phase) |
||
| 18 | Creatinine < 3×ULN |
||
| 19 | Creatinine =< 1.5 x ULN (=< 28 days prior to registration) |
||
| 20 | Renal insufficiency as indicated by a creatinine level >3 times ULN |
||
| 21 | Serum creatinine ? 2.0 × ULN |
||
| 22 | Serum creatinine =< 2 times ULN; timeline: within 3 weeks prior to enrollment |
||
| 23 | Within 30 days prior to enrollment: Creatinine less than 1.5 times the ULN |
||
| 24 | Creatinine ? 1.5 × ULN. |
||
| 25 | Creatinine ?1.5 ULN. |
||
| 26 | Serum creatinine =< 1.5 ULN |
||
| 27 | Creatinine ? 1.5 ULN |
||
| 28 | Serum creatinine =< 1.5 x ULN |
||
| 29 | Serum creatinine =< 1.5 x ULN |
||
| 30 | Renal: Serum creatinine ? 1.5 times ULN. |
||
| 31 | Creatinine =< 2.0 x ULN |
||
| 32 | Serum creatinine < 1.5 x ULN |
||
| 33 | Creatinine =< 2 X institutional ULN (documented within 28 days of registration) |
||
| 34 | Serum creatinine =< 1.5 x the IULN |
||
| 35 | Creatinine =< 2 x ULN obtained =< 14 days prior to registration |
||
| 36 | Creatinine ?1.5 ULN OR |
||
| 37 | Serum creatinine =< 1.5 x institutional ULN |
||
| 38 | Have a serum creatinine ?1.5 × ULN. |
||
| 39 | Creatinine ? 1.5 x ULN |
||
| 40 | Creatinine ?1.5 ULN. |
||
| 41 | Serum creatinine =< 1.5 x institutional ULN |
||
| 42 | Serum creatinine =< 2.0 x ULN |
||
| 43 | Serum creatinine =< 1.5 x institutional ULN |
||
| 44 | Serum creatinine =< 1.5 x institutional ULN OR |
||
| 45 | Creatinine =< 1.5 x ULN |
||
| 46 | Serum creatinine < 2.5 times ULN |
||
| 47 | Serum creatinine =< 1.5 x ULN, OR |
||
| 48 | Creatinine =< 2.5 x ULN |
||
| 49 | Serum creatinine =< 1.5 x institutional ULN |
||
| 50 | Creatinine =< 1.5 x ULN |
||
| 51 | Serum creatinine =< 1.5 x institutional ULN within 14 days prior to start of protocol therapy. |
||
| 52 | Serum creatinine =< 1.5 x institutional ULN |
||
| 53 | Serum creatinine < 2 x ULN |
||
| 54 | Serum creatinine < 2.5 times ULN |
||
| 55 | Renal: creatinine ? 2x of ULN for age |
||
| 56 | Creatinine =< 1.5 x ULN |
||
| 57 | Serum creatinine =< 1.5 x the ULN |
||
| 58 | Serum creatinine =< 1.5 x the ULN |
||
| 59 | OBTAINED =< 7 DAYS PRIOR TO REGISTRATION: Creatinine =< 1.5 x ULN |
||
| 60 | Creatinine =< 2 x ULN =< 28 days prior to registration |
||
| 61 | Abnormal renal function (serum creatinine > 2 x ULN) |
||
| 62 | Serum creatinine =< 2 x ULN |
||
| 63 | Acceptable renal function: *Serum creatinine ? 1.5 times the ULN. |
||
| 64 | Serum creatinine =< 1.5 x ULN |
||
| 65 | Creatinine up to 1.5 x ULN. |
||
| 66 | Serum creatinine =< 1.5 x ULN |
||
| 67 | Serum creatinine =< 1.5 x ULN |
||
| 68 | Creatinine =< 1.5 x institutional ULN |
||
| 69 | Creatinine =< 2 X institutional ULN |
||
| 70 | Serum creatinine =< 1.5 x ULN |
||
| 71 | Creatinine > 1.5 x ULN |
||
| 72 | Creatinine < 1.5 times ULN. |
||
| 73 | Obtained =< 14 days prior to registration: Creatinine =< 1.5 x ULN |
||
| 74 | Renal function: serum creatinine ? 1.5 times the ULN range of each institution. |
||
| 75 | Serum creatinine =< 1.5 x ULN |
||
| 76 | Serum creatinine < 2 x ULN |
||
| 77 | Serum creatinine =< 2 x the ULN |
||
| 78 | Creatinine < 2 |
||
| 79 | Renal: Serum creatinine < 2.0 x ULN or creatinine clearance ? 50 mL/min/1.73m^2 for patients with serum creatinine levels above 2 x ULN. |
||
| 80 | Serum creatinine =< 1.5 x ULN |
||
| 81 | Serum creatinine =< 2.5 X ULN |
||
| 82 | Creatinine =< 1.5 x ULN |
||
| 83 | Obtained =< 14 days prior to registration: Creatinine =< 1.5 x ULN OR |
||
| 84 | Serum creatinine ? 1.5 x ULN |
||
| 85 | Creatinine =< 1.5 x ULN |
||
| 86 | Serum creatinine =< 2.5 |
||
| 87 | Serum creatinine ? 2.5 |
||
| 88 | Subjects above specific amount of serum creatinine. |
||
| 89 | Within 7 days (+ 3 day window) of enrollment: Serum creatinine of =< 1.5 x institutional ULN |
||
| 90 | REP ELIGIBILITY: Serum creatinine of =< 1.5 x institutional ULN |
||
| 91 | Serum creatinine =< 1.5 x ULN (results within 7 days before study drug administration) |
||
| 92 | Creatinine < 1.5 X baseline, < 1.5 X ULN OR |
||
| 93 | Creatinine =< 2.5 x ULN |
||
| 94 | Creatinine =< 1.5 x ULN |
||
| 95 | Serum creatinine =< 1.5 times ULN |
||
| 96 | (For both cohorts A and B): Serum creatinine =< 1.5 x ULN |
||
| 97 | Creatinine ? 1.5x ULN; |
||
| 98 | Serum creatinine =< 1.5 x the ULN |
||
| 99 | Serum creatinine =< 1.5 x ULN |
||
| 100 | Serum creatinine =< 1.5 x ULN OR |
||
| 101 | Creatinine ? 1.5x institutional ULN |
||
| 102 | Serum creatinine =< 1.5 ULN |
||
| 103 | Creatinine =< 1.2 x ULN prior to biopsy |
||
| 104 | Serum creatinine =< 1.5 x the ULN |
||
| 105 | Serum creatinine > 1.5 ULN |
||
| 106 | Serum creatinine < 1.5 x ULN |
||
| 107 | Creatinine =< ULN |
||
| 108 | Creatinine =< 1.5 x ULN |
||
| 109 | Creatinine =< 1.5 x institutional ULN |
||
| 110 | Creatinine =< 1.5 x ULN OR |
||
| 111 | Serum creatinine < 1.5 x ULN |
||
| 112 | Creatinine =< 1.5 x ULN obtained =< 14 days prior to registration |
||
| 113 | Renal function: Creatinine ? 2.0 × ULN |
||
| 114 | Serum creatinine ?1.5 x ULN |
||
| 115 | Creatinine =< 1.5 times ULN |
||
| 116 | Creatinine < 1.5 times ULN |
||
| 117 | Serum creatinine =< 1.5 x ULN |
||
| 118 | Serum creatinine =< 1.5 X ULN (CTCAE grade 1 baseline) |
||
| 119 | Creatinine =< 1.5 times ULN |
||
| 120 | Obtained within 14 days prior to registration; serum creatinine ? 1.5 x ULN |
||
| 121 | Serum creatinine =< 1.5 X ULN |
||
| 122 | Creatinine =< 1.5 x institutional ULN OR |
||
| 123 | Serum creatinine =< 1.5 x ULN |
||
| 124 | Creatinine =< 1.5 x ULN |
||
| 125 | Creatinine ? 1.5 × ULN |
||
| 126 | Renal function (creatinine <1.5 × ULN) |
||
| 127 | Renal function (creatinine <1.5 × ULN) |
||
| 128 | Within 14 days prior to registration: Serum creatinine < 1.5 x ULN |
||
| 129 | Serum creatinine =< 3 x ULN for age |
||
| 130 | Serum creatinine =< 1.5 x ULN |
||
| 131 | Creatinine < 2.0 x ULN |
||
| 132 | Serum creatinine =< 1.5 x ULN |
||
| 133 | Serum Creatinine < 2.5 X ULN |
||
| 134 | Creatinine serum levels ? 1.5 x ULN |
||
| 135 | Adequate organ function as indicated by the following laboratory values. All laboratory tests must be obtained within 7 days prior to the first dose of ARQ 751: a. Hematological i. Absolute neutrophil count (ANC) ? 1.5 x 109/L ii. Platelet count (Plt) ? 100 x 109/L iii. Hemoglobin (Hb) ? 9 g/dL iv. International normalized ratio (INR) 0.8 to upper limit of normal (ULN) or ? 3 for subjects receiving anticoagulant therapy such as Coumadin or heparin b. Renal i. Serum creatinine ? 1.5 x ULN or calculated creatinine clearance ? 60 mL/min/1.73 m2 for subjects with serum creatinine levels > 1.5 x institutional ULN c. Hepatic i. Total bilirubin ? 1.5 x ULN ii. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ? 3 x ULN or ? 5 x ULN for subjects with known liver metastases d. Metabolic i. Glycated hemoglobin (HbA1c) ? 8% |
||
| 136 | Serum creatinine =< 1.5 x ULN (CTCAE grade 1 baseline) |
||
| 137 | Creatinine < or = 2 |
||
| 138 | PRIOR TO CELL PROCUREMENT: Serum creatinine ? 1.5 times ULN |
||
| 139 | PRIOR TO INFUSION OF ATLCAR.CD30 CELLS: Serum creatinine ? 1.5 times ULN |
||
| 140 | Creatinine < 1.5 x ULN |
||
| 141 | Serum creatinine > 1.5 x ULN |
||
| 142 | Creatinine > 1.5 x ULN |
||
| 143 | Serum creatinine =<1.5 times the ULN or |
||
| 144 | Creatinine up to 1.5 ULN, or |
||
| 145 | Creatinine > 1.5 ULN, or |
||
| 146 | Creatinine =< 2.0 |
||
| 147 | Serum creatinine ?1.5 x ULN |
||
| 148 | Within 14 days prior to study entry: Serum creatinine =< 1.5 x ULN |
||
| 149 | Serum creatinine < 3 x IULN |
||
| 150 | Kidney function: creatinine < 2.5 x ULN. |
||
| 151 | Serum creatinine =< 1.5 x ULN |
||
| 152 | Creatinine > 2.0 x ULN |
||
| 153 | Creatinine < 1.5 x ULN |
||
| 154 | Serum creatinine =< 1.5 x ULN |
||
| 155 | Serum creatinine =< 1.5 x ULN |
||
| 156 | Has serum creatinine < 1.5 × ULN |
||
| 157 | Creatinine =< 2 x ULN |
||
| 158 | Creatinine =< 1.5 x ULN |
||
| 159 | Creatinine =< 1.3 |
||
| 160 | Serum creatinine =< 1.5 x ULN, obtained =< 14 days prior to registration |
||
| 161 | Serum creatinine performed within 4 weeks prior to study entry must be less than or equal to 1.5 x ULN for the lab. |
||
| 162 | Serum creatinine =< 1.5 x ULN |
||
| 163 | Creatinine =< 1.5 |
||
| 164 | Creatinine =< 2.0 |
||
| 165 | Serum creatinine < or = to 2.5 x ULN |
||
| 166 | Creatinine =<1.5 x ULN |
||
| 167 | Serum creatinine =< 1.5 x ULN |
||
| 168 | Serum creatinine < 2.5 times ULN, OR |
||
| 169 | Creatinine =< 1.5 x ULN (obtained =< 7 days prior to registration) |
||
| 170 | Serum creatinine =< 1.5 x ULN |
||
| 171 | Creatinine =< 1.5 x ULN |
||
| 172 | Serum creatinine =< 1.5 x ULN |
||
| 173 | Creatinine < 2 x ULN |
||
| 174 | Serum creatinine =< 3 x ULN for age |
||
| 175 | Creatinine =< 1.5 times ULN |
||
| 176 | Creatinine < 2.5 x ULN |
||
| 177 | Sorafenib\r\n* Creatinine (Crt) < 1.5 X ULN |
||
| 178 | Serum creatinine < 1.5 times the institutional ULN |
||
| 179 | Patients must have adequate Hematologic function(ANC ? 1,500/mcl and platelets ? 100,000/mcl), Renal function(serum creatinine ? ULN or calculated creatinine clearance ? 60 mL/min), Hepatic function(serum bilirubin ? 1.5 x ULN and AST ? 2.5 x ULN and ALT? 2.5 x ULN) |
||
| 180 | Creatinine =< 1.5 x ULN |
||
| 181 | Serum creatinine =< 2.0 x local institutional ULN |
||
| 182 | Serum creatinine < 1.5 x institutional ULN |
||
| 183 | Serum creatinine =< 1.5 x ULN |
||
| 184 | Serum creatinine =< 2.0 |
||
| 185 | AST and ALT < 5 times ULN; ALP < 5 times ULN; Bilirubin ? 1.5 times ULN; Creatinine ? 1.5 times ULN and eGFR ? 50. |
||
| 186 | Serum creatinine < 2.0 |
||
| 187 | Renal function: Serum creatinine >1.5x ULN |
||
| 188 | Creatinine < 1.8 |
||
| 189 | Renal: Serum creatinine < 1.5 x ULN or creatinine clearance ?60 mL/min/1.73m2 for patients with serum creatinine levels above 1.5 x ULN. |
||
| 190 | creatinine ? 1.5 × ULN,, |
||
| 191 | Serum creatinine concentration < 1.5 x ULN |
||
| 192 | Have adequate organ function, confirmed by the following laboratory values obtained ? 3 days prior to the first treatment: absolute neutrophil count ? 1.5 × 10^9/L; hemoglobin ? 9 g/dL; platelets ? 100 × 10^9/L; aspartate transaminase and alanine transaminase ? 2.5 × upper limit of normal (ULN); serum total bilirubin ? 2.0 × ULN; serum creatinine ? 1.5 × ULN, or estimated or measured creatinine clearance ? 60 mL/min; prothrombin time, activated partial thromboplastin time ? 1.5 × ULN if not on anticoagulation therapy |
||
| 193 | Renal insufficiency or serum creatinine >1.5 X ULN at screening. |
||
| 194 | Serum creatinine < 1.5 times ULN |
||
| 195 | Total serum creatinine ? 1.5 × ULN |
||
| 196 | Serum creatinine < 1.5 x ULN |
||
| 197 | plasma creatinine less than or equal to 1.5 x institutional ULN OR |
||
| 198 | Creatinine (Cr) =< 1.5 x ULN |
||
| 199 | Serum creatinine ?2.0 x ULN |
||
| 200 | Creatinine =< 1.5 x ULN |
||
| 201 | Creatinine < 2 X ULN |
||
| 202 | Creatinine > 1.5 x ULN. |
||
| 203 | Creatinine =< 1.5 x ULN |
||
| 204 | Creatinine =< 1.5 ULN |
||
| 205 | At cycle 1 day 1 pre-dosing: Creatinine > 2 x ULN |
||
| 206 | Creatinine < 1.5 x ULN |
||
| 207 | Serum creatinine =< 1.5 x the ULN |
||
| 208 | Serum creatinine =< 1.5 times the ULN |
||
| 209 | Creatinine =< institutional ULN |
||
| 210 | Creatinine =< 1.5 x ULN |
||
| 211 | Within 28 days of study registration: Creatinine < 2.0 x the institutional ULN |
||
| 212 | Serum creatinine =< grade 1 |
||
| 213 | Creatinine =< grade 1 |
||
| 214 | Creatinine < 1.5 |
||
| 215 | Creatinine =< 1.5 x ULN OR |
||
| 216 | Creatinine < 2.0 |
||
| 217 | ARM A: obtained =< 14 days prior to registration: \r\n* Creatinine =< 1.5 x ULN |
||
| 218 | ARM B: obtained =< 14 days prior to registration: \r\n* Creatinine =< 1.5 x ULN |
||
| 219 | Creatinine =< 1.5 x ULN |
||
| 220 | Creatinine =< 1.5 x ULN, obtained =< 14 days prior to registration OR |
||
| 221 | Creatinine =< 1.5 x ULN |
||
| 222 | Creatinine =< 1.5 x the institutional ULN |
||
| 223 | Serum creatinine =< 1.5 x ULN |
||
| 224 | Serum creatinine > 2 x ULN |
||
| 225 | Creatinine =< 1.5 x ULN |
||
| 226 | Creatinine =< 2.5 x ULN |
||
| 227 | Creatinine =< 1.5 x ULN |
||
| 228 | Creatinine =< 1.5 x ULN |
||
| 229 | Creatinine =< 2.0 x ULN |
||
| 230 | Serum creatinine =< 1.5 x the ULN |
||
| 231 | Serum creatinine < 2 x the institutional ULN |
||
| 232 | Creatinine =< 2.0 x ULN |
||
| 233 | Serum creatinine < 2 x the institutional ULN; however, if serum creatinine > 1.5 x ULN, a 24 hour urine creatinine clearance must be > 50 ml/min unless there is renal involvement by lymphoma |
||
| 234 | Creatinine < 1.5 |
||
| 235 | Serum creatinine =< 2 |
||
| 236 | Serum creatinine < 1.5 x ULN |
||
| 237 | Creatinine =< 1.5 x ULN |
||
| 238 | Creatinine < 2.0 |
||
| 239 | Creatinine =< 1.5 x ULN |
||
| 240 | Creatinine =< 2 x ULN |
||
| 241 | Serum creatinine =< 1.5 x IULN |
||
| 242 | Creatinine =< 1.5 times ULN |
||
| 243 | Serum creatinine =< 1.5 x ULN |
||
| 244 | Creatinine =< 1.5 x ULN |
||
| 245 | Renal: Creatinine > 1.5x ULN |
||
| 246 | Creatinine =< 1.5 x ULN OR |
||
| 247 | Serum creatinine ? 1.5 X ULN (CTCAE Grade 1 baseline) |
||
| 248 | Inadequate organ function immediate prior to randomization including: Hemoglobin <10g/dL (100g/L); ANC < 2000/mm³ (< 2.0 x 109/L); Platelets <100,000/mm³ (< 100 x 109/L); AST or ALT >1.5 x upper limit of normal (ULN); alkaline phosphatase > 2.5 x ULN, total serum bilirubin > 1.25 x ULN; serum creatinine >1.25 x ULN or estimated creatinine clearance < 60 mL/min as calculated using the method standard for the institution; severe and relevant co-morbidity that would interact with the participation in the study |
||
| 249 | S. Creat. > 1.5 x ULN. |
||
| 250 | Renal: Creatinine > 1.5x ULN. |
||
| 251 | Serum creatinine > 2.5 × ULN. MDS Cohort: |
||
| 252 | Creatinine ? 1.5 x ULN or 24-hour urine < Grade 2 |
||
| 253 | Renal: Creatinine > 1.5x ULN |
||
| 254 | Creatinine < 2.0 × ULN |
||
| 255 | Serum creatinine performed within 28 days of randomization must be less than or equal to 1.5 x ULN for the lab. |
||
| 256 | SUB-PROTOCOL AIM A: Serum creatinine =< 1.5 x ULN |
||
| 257 | Serum creatinine at least 1.5 × ULN |
||
| 258 | Creatinine <1.5 X institutional ULN OR |
||
| 259 | Renal: Serum creatinine ? 1.5 x ULN, or for patients with serum creatinine > 1.5 ULN, creatinine clearance ? 50 mL/min. |
||
| 260 | Creatinine < 1.5 x ULN |
||
| 261 | Creatinine =< 1.5 x the ULN |
||
| 262 | Serum creatinine =< 2 x ULN |
||
| 263 | Serum creatinine =< 2 x ULN |
||
| 264 | Serum creatinine =< 1.5 x ULN, obtained within 14 days prior to initiation of study treatment |
||
| 265 | Serum creatinine > 1.5 x ULN |
||
| 266 | S-creatinine and S-bilirubin ? 1.5 x ULN. S-ALAT and S-ASAT ? 2.5 x ULN (or ?5 in case of liver metastases) |
||
| 267 | Serum creatinine ? 1.5 x ULN |
||
| 268 | Serum creatinine equal to or less than 1.5 x ULN |
||
| 269 | Creatinine ? 2.5 x ULN |
||
| 270 | Creatinine <= 1.5 x ULN. |
||
| 271 | Creatinine < or equal to 1.5 x ULN |
||
| 272 | Renal: Serum creatinine 1.5 times ULN. |
||
| 273 | Creatinine < 1.5 x ULN |
||
| 274 | Creatinine < 2.0 |
||
| 275 | Serum creatinine < 1.5 times ULN |
||
| 276 | Creatinine =< 1.5 |
||
| 277 | Creatinine =< 1.5 x ULN |
||
| 278 | Serum Creatinine ? 1.5X ULN |
||
| 279 | Serum creatinine < 3 x ULN |
||
| 280 | Creatinine =< 1.5 x ULN |
||
| 281 | Creatinine =< 1.5 x ULN for age |
||
| 282 | Serum creatinine =< 1.5 x ULN |
||
| 283 | Serum creatinine < 2.0 x ULN |
||
| 284 | Creatinine =< 1.5 x ULN |
||
| 285 | Serum creatinine < 1.5 x ULN |
||
| 286 | Creatinine < 2 X ULN |
||
| 287 | Creatinine less than 1.5 x ULN |
||
| 288 | Serum creatinine ? 1.5 x ULN |
||
| 289 | Serum creatinine < 1.5 x ULN (within 7 days prior to registration) |
||
| 290 | Creatinine > 1.5 x ULN |
||
| 291 | Within 4 weeks of administration of study therapy: Serum creatinine =< 1.5 x ULN |
||
| 292 | Serum creatinine 1.5 x ULN |
||
| 293 | Renal insufficiency as indicated by a creatinine level > 2 x the ULN. |
||
| 294 | Creatinine =< 1.5 X ULN |
||
| 295 | Serum creatinine =< 1.5 x ULN |
||
| 296 | Serum creatinine =< 1.5 x the ULN |
||
| 297 | Serum creatinine ? 1.5 × ULN |
||
| 298 | Serum creatinine =< 1.5 x ULN (obtained =< 7 days prior to randomization) |
||
| 299 | Creatinine =< 1.5 x ULN |
||
| 300 | Serum creatinine =< ULN |
||
| 301 | Serum creatinine < 1.5 x ULN |
||
| 302 | Creatinine =< 1.5 x ULN |
||
| 303 | Creatinine =< 1.5 x ULN |
||
| 304 | Creatinine =< 1.5 x ULN |
||
| 305 | Serum creatinine level =< IULN |
||
| 306 | Serum creatinine =< 1.5 x the ULN |
||
| 307 | Creatinine =< 1.5 x ULN |
||
| 308 | Creatinine =< 1.5 X ULN |
||
| 309 | Serum creatinine > 1.5 x ULN |
||
| 310 | Serum creatinine =< 1.5 x the ULN |
||
| 311 | Serum creatinine =< 1.5 x ULN |
||
| 312 | Serum creatinine ?1.5 x ULN |
||
| 313 | Serum creatinine =< 1.5 x ULN |
||
| 314 | COHORT B: Creatinine =< 2.0 x ULN |
||
| 315 | Serum creatinine ? 2.0 x ULN |
||
| 316 | Serum creatinine =< 1.5 x ULN |
||
| 317 | Creatinine ? 1.5 × ULN |
||
| 318 | Serum creatinine performed within 4 weeks prior to study entry must be less than or equal to 1.5 x ULN for the lab. |
||
| 319 | Creatinine =< 1.5 x ULN |
||
| 320 | Creatinine =< ULN x 1.5 |
||
| 321 | Serum creatinine =< 1.5 x ULN |
||
| 322 | Creatinine < 1.5 x ULN |
||
| 323 | Creatinine =< 2 x ULN |
||
| 324 | Creatinine =< 1.5 x ULN |
||
| 325 | Serum creatinine =< 1.5 x ULN |
||
| 326 | Creatinine =< 1.5 x institutional ULN |
||
| 327 | Serum creatinine =< 1.5 X institutional ULN |
||
| 328 | Obtained =< 7 days prior to registration: Creatinine =<1.5 x ULN |
||
| 329 | Creatinine =< 1.5 x ULN |
||
| 330 | Serum creatinine >= 2.0 |
||
| 331 | Obtained =< 7 days prior to registration: Creatinine =< 1.5 x institutional ULN |
||
| 332 | Serum creatinine =< 1.5 x ULN |
||
| 333 | Serum creatinine < 1.5 x ULN |
||
| 334 | Serum creatinine =< 2.0 x ULN |
||
| 335 | Creatinine < 1.5 X institutional ULN |
||
| 336 | Serum creatinine < 1.5 time the institutional ULN |
||
| 337 | Serum creatinine less than or equal to 2 x ULN |
||
| 338 | Creatinine < 1.5 |
||
| 339 | Creatinine < 2.0 |
||
| 340 | Serum creatinine =< 1.5 x ULN |
||
| 341 | Serum creatinine < 2 x ULN |
||
| 342 | Serum creatinine < 1.5 x ULN OR |
||
| 343 | Serum creatinine =< 1.5 x ULN |
||
| 344 | Renal Status (within 30 days prior to randomization): a) Creatinine no greater than 1.5 times ULN |
||
| 345 | Creatinine =< 1.5 x ULN |
||
| 346 | Serum creatinine =< 1.5 X ULN |
||
| 347 | Serum creatinine =< 1.5 x ULN |
||
| 348 | Serum creatinine concentration =< 2 x ULN |
||
| 349 | Creatinine =< 2.5 x ULN |
||
| 350 | Creatinine < 2 x ULN |
||
| 351 | Serum creatinine concentration <2x ULN |
||
| 352 | Creatinine =< 1.7 |
||
| 353 | Serum creatinine ? 1.5 x ULN |
||
| 354 | Within 8 weeks of randomization: Serum creatinine =< 1.5 x ULN |
||
| 355 | Serum creatinine < 1.5 x of ULN |
||
| 356 | Creatinine < 2 x ULN |
||
| 357 | Serum creatinine =< 1.5 x ULN |
||
| 358 | Creatinine =< 2.0 x ULN |
||
| 359 | Creatinine 1.5 x ULN |
||
| 360 | Serum creatinine >1.5x ULN at screening |
||
| 361 | Serum Creatinine < 2.0 times the institutional ULN |
||
| 362 | 1.5 x ULN |
||
| 363 | Serum creatinine < 1.5 x ULN |
||
| 364 | Serum creatinine =< 1.5 x normal |
||
| 365 | Creatinine < 1.5 x ULN |
||
| 366 | Creatinine less than 1.5 |
||
| 367 | Serum creatinine =< 1.5 x ULN or creatinine clearance (CrCl) of >= 30 |
||
| 368 | Serum creatinine =< 2 x ULN |
||
| 369 | Creatinine =< 1.5 x ULN |
||
| 370 | Serum creatinine =< 1.5 x the ULN |
||
| 371 | Serum creatinine ? 1.5 x ULN |
||
| 372 | Serum creatinine ? 1.5 x ULN |
||
| 373 | Serum creatinine =< 1.5 x the ULN |
||
| 374 | Serum creatinine =< 2.0 X ULN |
||
| 375 | Serum creatinine</=1.5 times the ULN |
||
| 376 | Creatinine < 1.5 x ULN |
||
| 377 | Serum creatinine ? 1.5 x ULN |
||
| 378 | Serum creatinine < 1.5 x ULN or creatinine (Cr) > 1.5 x ULN, but calculated clearances of > 60 |
||
| 379 | Creatinine >2.0x ULN |
||
| 380 | Serum creatinine =< 1.5 x ULN or creatinine (Cr) > 1.5 x ULN, but calculated clearances of > 60 |
||
| 381 | Serum creatinine =< 1.5 x ULN for the lab |
||
| 382 | Creatinine =< 1.5 x institutional ULN |
||
| 383 | Creatinine =< 2 X ULN |
||
| 384 | Creatinine =< 1.5 X ULN |
||
| 385 | Serum creatinine < 2.0 x ULN |
||
| 386 | Has adequate organ function: AST and ALT < 3X the ULN, serum bilirubin < 2X the ULN, serum creatinine of < 2 mg/dL, or a calculated creatinine clearance of > 50 mL/minute |
||
| 387 | Renal function: creatinine ? 1.5 x ULN |
||
| 388 | Creatinine > 1.5 × ULN |
||
| 389 | Serum creatinine =< 2 times ULN |
||
| 390 | Serum creatinine (sCr) ? 1.5 x ULN; |
||
| 391 | Serum creatinine =< 1.5 x ULN |
||
| 392 | Serum creatinine > 1.5 x ULN. |
||
| 393 | Serum creatinine =< 1.5 x ULN |
||
| 394 | Serum creatinine ? 1.5 x ULN |
||
| 395 | Serum creatinine < 1.5 x ULN |
||
| 396 | Creatinine (renal function) =< 1.5 X ULN |
||
| 397 | Creatinine =< 1.5 x Institutional ULN obtained =< 7 days prior to registration |
||
| 398 | Must have adequate organ function as defined by the following baseline values: Absolute neutrophil count >=1.5 x 10^9/Liter, Hemoglobin >=9 gram (g)/decilitre(dL), Platelets >=100 x 10^9/L, Partial thromboplastin time (PTT) <=1.25 x upper limit of normal (ULN), Albumin >=2.5 g/dL, Serum total bilirubin <=1.25 times ULN (for Arm B: <=ULN ), Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) <=2.5 times ULN (for Arm B: <=1.5 times ULN), Serum Creatinine <=1.5 x ULN, Or Measured or Calculated Creatinine Clearance >=45 mL/min (Arm A or B), >=65 mL/min (Arm C), Left ventricular ejection fraction >=50% by ECHO. |
||
| 399 | Serum creatinine < 2 x ULN |
||
| 400 | Serum creatinine < 1.5 × ULN |
||
| 401 | serum creatinine ?1.5 X ULN |
||
| 402 | Serum creatinine ?1.5 ULN. |
||
| 403 | Creatinine =< ULN |
||
| 404 | Serum creatinine =< 1.5 x the ULN |
||
| 405 | Creatinine < 3 x ULN |
||
| 406 | Creatinine < 2.0 |
||
| 407 | Creatinine > 2.0 |
||
| 408 | Creatinine =< 1.5 x ULN |
||
| 409 | Serum creatinine ?1.5 x ULN or creatinine clearance > 60 mL/min/1.73 m^2 for subjects with creatinine levels >1.5 x ULN |
||
| 410 | Serum creatinine < 2 x ULN |
||
| 411 | Patients with creatinine more than 1.5 x the ULN |
||
| 412 | Creatinine >= 1.5 times ULN |
||
| 413 | Creatinine less than 2.5 X ULN |
||
| 414 | Renal: Serum creatinine less than or equal to 1.5 times ULN. |
||
| 415 | Creatinine =< 1.5 X ULN |
||
| 416 | Serum creatinine =< 1.5 x ULN |
||
| 417 | Creatinine =< 2 X ULN |
||
| 418 | Creatinine =< 1.5 x ULN |
||
| 419 | Serum creatinine =< 2 x ULN |
||
| 420 | Serum creatinine =< 1.5 x ULN |
||
| 421 | Urea and serum creatinine < 2.5 times ULN |
||
| 422 | Serum creatinine =< 1.5 times the ULN |
||
| 423 | Serum creatinine < 2 x ULN |
||
| 424 | Serum creatinine =< 1.5 x ULN |
||
| 425 | Creatinine > 1.5 x ULN |
||
| 426 | Serum creatinine =< 1.5 X ULN |
||
| 427 | Serum creatinine =< 1.5 x ULN |
||
| 428 | Creatinine =< 1.5 x ULN |
||
| 429 | Serum creatinine < 2.0 x ULN |
||
| 430 | Obtained within 14 days prior to initiation of treatment: Serum creatinine =< 1.5 times ULN |
||
| 431 | Serum creatinine >= 2.5 x ULN 14 days prior to study enrollment |
||
| 432 | Creatinine > 2.0 |
||
| 433 | Creatinine =< 1.2 X ULN obtained =< 180 days prior to registration |
||
| 434 | Serum creatinine =< 1.5 x the ULN |
||
| 435 | Serum creatinine > 2.0 |
||
| 436 | Serum creatinine greater than 3.0 |
||
| 437 | Serum creatinine =< 2 |
||
| 438 | Serum creatinine =< 2.0 x IULN |
||
| 439 | Creatinine =< 2 x ULN |
||
| 440 | Creatinine =< 1.5 x ULN |
||
| 441 | Creatinine =< 1.3 |
||
| 442 | Serum creatinine =< 1.5 times institutional ULN |
||
| 443 | Creatinine =< 1.5 x institutional ULN |
||
| 444 | Creatinine < 2 x ULN |
||
| 445 | Creatinine =< 1.5 x institutional ULN |
||
| 446 | Creatinine =< 1.5 |
||
| 447 | Creatinine =< ULN |
||
| 448 | Creatinine =< 1.5 x institutional ULN |
||
| 449 | Serum creatinine < 2 x ULN |
||
| 450 | Serum creatinine < 1.5 x ULN |
||
| 451 | Creatinine < 2.0 |
||
| 452 | Serum creatinine =< 1.5 times ULN |
||
| 453 | Serum creatinine =< 1.5 x ULN |
||
| 454 | Creatinine < 2 x ULN |
||
| 455 | Serum creatinine =< 1.5 x institutional ULN |
||
| 456 | Creatinine kinase =< 2.5 x the ULN, within 30 days prior to enrollment |
||
| 457 | Serum creatinine =< institutional ULN |
||
| 458 | Serum creatinine =< 1.5 x ULN |
||
| 459 | Serum creatinine ? 1.5 x ULN |
||
| 460 | Serum creatinine within 1.5 times the institution’s ULN |
||
| 461 | Creatinine within 2 x ULN |
||
| 462 | Plasma creatinine =< 1.6 |
||
| 463 | Serum creatinine < 2.0 |
||
| 464 | Creatinine > 2.0 x ULN |
||
| 465 | Patients with a history of renal disease or patients over 70 with a creatinine > 1.3; creatinine must have been done within the last 12 weeks |
||
| 466 | Renal function: serum creatinine ?1.5 times the ULN range of each institution. |
||
| 467 | Creatinine <1.5 X ULN |
||
| 468 | Elevated serum creatinine of > 2 |
||
| 469 | Renal lab values: Creatinine > 1.5 ULN |
||
| 470 | Creatinine < ULN, performed within 28 days prior to registration |
||
| 471 | Creatinine < 2 X institutional ULN |
||
| 472 | Serum creatinine =< 1.5 x ULN |
||
| 473 | Greater than 1.5 x the ULN for creatinine |
||
| 474 | Serum creatinine =< within 1.5 x ULN |
||
| 475 | Creatinine < 1.2 |
||
| 476 | Serum creatinine < 1.5 x ULN |
||
| 477 | Creatinine >1.5 x ULN |
||
| 478 | Serum creatinine < 1.5 x ULN |